BCAL Diagnostics appoints Shane Ryan as new CEO
SYDNEY, AUSTRALIA: BCAL Diagnostics Limited (ASX:BDX) has announced the appointment of Shane Ryan as the new CEO, effective from April 2, 2024. Ryan, previously the company’s COO, will lead the launch of the innovative breast cancer test, BREASTEST™, and drive…